from Reuters: Health News https://ift.tt/2uiKll4
Sunday, March 24, 2019
Sunday, March 24, 2019
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Eisai Co Ltd on Friday said it has begun phase 3 clinical trials of Alzheimer's treatment BAN2401, a day after the Japanese drugmaker and U.S. partner Biogen Inc scrapped trials for another Alzheimer's drug, aducanumab.

from Reuters: Health News https://ift.tt/2uiKll4
from Reuters: Health News https://ift.tt/2uiKll4
Related Posts:
LATEST HEALTH NEWSThe U.S. Environmental Protection Agency (EPA) said on Tuesday that glyphosate, a chemical in many popular weed killers, is not a carcinogen, contradicting decisions by U.S. juries that found it caused cancer in people. … Read More
LATEST HEALTH NEWS(Reuters Health) - Croup, a common upper respiratory tract infection in young children under age 6, can become severe and require hospitalization, doctors say in a new patient resource published in JAMA. from Reuters: He… Read More
LATEST HEALTH NEWSMerck & Co said on Wednesday it has increased production of the measles vaccine to meet an uptick in demand in the United States in the midst of the country's biggest outbreak in 25 years. from Reuters: Health News h… Read More
LATEST HEALTH NEWS(Reuters Health) - Teens with painful chronic illnesses may find that YouTube can provide a support network, a new study suggests. from Reuters: Health News https://reut.rs/2WgYewj … Read More
LATEST HEALTH NEWS(Reuters Health) - Looking online for alternative medicine providers to diagnose or treat celiac disease is a bad idea because many websites market unproven or ineffective tests and treatments, researchers say. from Reut… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment